CRH PLC has been a steady performer in the building materials and construction sector, riding waves of infrastructure demand and strategic expansions to deliver solid growth for investors. As a global leader in aggregates, asphalt, and ready-mixed concrete—think highways, homes, and everything in between—this Irish-headquartered giant (now with a big U.S. footprint) has navigated economic cycles, including the COVID slowdown and post-pandemic booms. With revenue climbing consistently and margins expanding, it’s worth unpacking the fundamentals to see if the recent stock price around its latest close offers a buy, hold, or pass for everyday investors like us.
Revenue Growth and Operational Momentum
Let’s start with the top line, because revenue tells you if a company’s got real demand behind it. CRH’s sales have grown from $30 billion in 2016 to $35.6 billion in 2024—a robust 19% increase over eight years, averaging about 2.4% annually compounded, but accelerating lately with 18% growth from 2020’s pandemic dip of $27.6 billion. Analysts project even more juice ahead: 6% growth to $37.6 billion in 2025 and pushing toward $42.1 billion by 2027, fueled by U.S. infrastructure spending from the 2021 Bipartisan Infrastructure Law, which poured billions into roads and bridges—CRH’s sweet spot.
Per-employee revenue efficiency shines too, rising from $346k in 2016 to $446k in 2024 (29% up), even as headcount stabilized around 78,000-80,000 workers. This isn’t fluff; it signals smarter operations amid labor squeezes. Gross margins back this up, edging from 32.6% in 2016 to a healthy 35.7% last year (10% relative improvement), thanks to pricing power in commodities like cement and aggregates. Why care? Strong margins mean the company keeps more cash from sales to reinvest or return to shareholders, buffering against cost spikes like energy or freight.
Earnings before tax (EBT) exploded from $1.9 billion in 2016 to $4.7 billion in 2024 (145% surge), with EBT margins tripling to 13.3%—a profitability metric that screams efficiency gains. Net income, after some volatility (that 2018 $4 billion pop from one-offs), hit $3.5 billion last year, with forecasts climbing to $4.5 billion by 2027. Tie this to real-world moves: CRH’s $3.5 billion Ash Grove Cement acquisition in 2018 supercharged U.S. presence, and its 2023 shift to NYSE primary listing (with HQ in Atlanta) slashed cross-listing hassles, unlocking easier capital access.
Cash Flow and Capital Discipline
Cash is king for cyclical plays like construction, and CRH delivers. Operating cash flow ballooned from $2.6 billion in 2016 to $5 billion in 2024 (93% growth), while free cash flow (FCF)—op cash minus capex—hit $2.7 billion last year after dips. Per share, FCF stands at $3.93, down slightly from 2023’s $4.56 but still robust. Capex runs heavy at $2.3 billion in 2024 (up 35% from prior year), funding plants and acquisitions—smart for long-term moats, but it pressures short-term FCF. Analysts see FCF rebounding to $3.4-$3.9 billion in coming years as efficiency kicks in.
Shares outstanding dropped from 828 million in 2016 to 683 million in 2024 (18% reduction), likely buybacks boosting per-share metrics. Revenue per share? Up from $36 to $52 (44%), EPS from $1.66 to $5.06 (205%). Book value per share grew steadily to $32.88, underscoring balance sheet health. Debt is up to $14 billion total (from $8.6 billion in 2016, 62% rise), but net debt at $10.2 billion is manageable with $22.5 billion equity. ROE hit 15.8% last year (peak 17.7% in 2022), far above the 10% threshold for great capital allocators—proof management’s compounding your money well.
Valuation: Trading at a Premium, But Justified?
Valuations have stretched as growth kicked in. PE ratio ballooned from 11.8x in 2016 to 18.2x in 2024 (projected 22.6x next year), reflecting higher expectations but risk if growth stutters. PS ratio jumped to 1.8x, PB to 2.8x—premiums earned via ROIC of 9.7% (double 2016 levels). EV/FCF at 27x looks rich, but compare to EV/Sales forecasted at 2.3x-2.6x; it’s pricing in that revenue ramp.
Stock price action mirrors fundamentals: lows/highs from $17-43 in 2020 (COVID crash) to $66-104 in 2024, a multi-bagger run. Recent close sits below the average analyst target by about 13% downside to low target but 13% upside to mean and 30% to high. That’s optimism baked in, but not bubble territory—especially post-2023 NYSE move, which spiked liquidity and visibility.
Insider Activity: Caution or Confidence?
Insiders lean sellers lately, with total sell proceeds at $6 million versus a lone $148k buy by the Group General Counsel in May 2025 (1,492 shares). CEO sold ~4k shares in March 2025, COO offloaded 40k in August—routine diversification? But zero buys elsewhere over 12 months raises an eyebrow. In a bull market for stocks, light selling isn’t panic, but watch for patterns; confident insiders often buy dips.
Future Outlook: Infrastructure Tailwinds Ahead
Analysts aren’t shy: revenue +18% cumulative by 2027, EPS to $6.78 (34% from 2024), ROE holding 16-17%. Key drivers? U.S. infra boom (IIJA’s $1.2 trillion), Europe recovery, and bolt-ons like the 2024 Texas aggregates deals. Risks: recession hitting construction (2020 repeat?), inflation on inputs, or debt servicing if rates stay high. Yet, FCF projections support $2.8-2.9 billion annual capex, leaving room for dividends (yield ~1-2% historically) and buybacks.
Correlations pop: revenue growth tightly tracks EPS/FCF (r~0.9), margins lift ROE, and share shrinkage amplifies returns. Stock lagged early recovery (PE compressed to 3.9x in 2022) but caught up as profits proved real. At current levels, it’s fairly valued for growth stocks—13% mean upside rewards patience if infra spends flow.
Bottom line for retail folks: CRH’s not flashy tech, but a boringly beautiful compounder. Fundamentals scream resilience; pair with diversification, and it’s a portfolio anchor. If you’re building wealth like laying bricks—one solid layer at a time—this one’s worth stacking. (Word count: 1,128)